Arterial Inflow and Muscle Ischemia During Calf Stimulation With the Veinoplus Device
Primary Purpose
Peripheral Artery Disease
Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
electrical muscle stimulation
Sponsored by
About this trial
This is an interventional treatment trial for Peripheral Artery Disease
Eligibility Criteria
Inclusion Criteria:
- French native
- Stable stage 2 peripheral artery disease
- Patent femoral artery on both sides
- Age > 18 years
Exclusion Criteria:
- Pregnancy
- Adults protected by maw
Sites / Locations
- University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
electrical stimulation
Arm Description
Evaluation of the effect of calf stimulation on flow and tissue oxygenation
Outcomes
Primary Outcome Measures
arterial inflow
Ultrasound and doppler measurement of femoral inflow before, during and for 10 minutes after stimulation
Secondary Outcome Measures
Full Information
NCT ID
NCT01592812
First Posted
May 3, 2012
Last Updated
March 15, 2013
Sponsor
University Hospital, Angers
1. Study Identification
Unique Protocol Identification Number
NCT01592812
Brief Title
Arterial Inflow and Muscle Ischemia During Calf Stimulation With the Veinoplus Device
Official Title
Investigation of the Arterial Effects of the Veinoplus(r) Stimlator Device.
Study Type
Interventional
2. Study Status
Record Verification Date
March 2013
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
May 2012 (Actual)
Study Completion Date
May 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Angers
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Stimulation of arterial inflow to the lower limb is important to obtain functional improvement in peripheral artery diseased (PAD) patients with claudication. The clinical effect of muscle stimulation to increase arterial inflow and the direct evaluation of the regional blood flow impairment (RBFI) in the area of stimulation, have not been evaluated in PAD patients.
Fifteen adult patients with stable arterial claudication will participate. Recruitment will be performed among patients referred for exercise oxymetry (treadmill: 3.2km.h-1, 10% slope) After two minutes of rest, the gastrocnemius will be stimulated for 20 minutes at an increasing frequency rate with 5 min steps (1 Hz, 1.25 Hz, 1.5 Hz and 1.75 Hz) on the most symptomatic side.
The investigators record the tcpo2 value, arterial blood inflow with ultrasound of the femoral artery, and near infra-red spectrometry (NIRS) on both sides.
Patients will be instructed to report eventual contraction-induced pain in the stimulated calf.
Detailed Description
Investigations are conducted in an air-conditioned 22+/-2 °C room, with the patient comfortably seated on an armchair.
Measured ware started at rest and performed throughout the period pf stimulation and for 10 minutes after the end of the stimulation
Muscle stimulation:
We apply a series of 20 minutes of stimulation with the Veinoplus® device. The device delivers a stimulation of incremental rate with 5 minutes intervals, with 1 Hz, 1.25 Hz, 1.5 Hz and 1.75 Hz and then stops automatically.
Ultrasound measurements The Diameter of the superficial femoral artery was measured at rest on both sides before each study. The VTI of 3 cardiac cycles (three peaks systolic velocity) will be measured by duplex ultrasound imaging, to calculate the arterial inflow to the leg. Results will be expressed in l /min.
Tcpo2 recording TcpO2 is measured at the chest and on both calves with TCM 400 (Radiometer, DK). Results are expressed in DROP index(mmHg) values.
Near Infra-red spectroscopy (NIRS) We use the ARTinis NIRS device (ARTinis; NL) to estimate tissue saturation (StO2) on both gastrocnemius muscles of the leg.
Systemic hemodynamic parameters
Systemic and diastolic arterial pressures and heart rate are recorded every two minutes using Dinamap V100 (GE france).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peripheral Artery Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
electrical stimulation
Arm Type
Experimental
Arm Description
Evaluation of the effect of calf stimulation on flow and tissue oxygenation
Intervention Type
Device
Intervention Name(s)
electrical muscle stimulation
Other Intervention Name(s)
Veinoplus device
Intervention Description
Duration of the stimulation 20 minutes
Primary Outcome Measure Information:
Title
arterial inflow
Description
Ultrasound and doppler measurement of femoral inflow before, during and for 10 minutes after stimulation
Time Frame
during stimulation
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
French native
Stable stage 2 peripheral artery disease
Patent femoral artery on both sides
Age > 18 years
Exclusion Criteria:
Pregnancy
Adults protected by maw
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Pierre Abraham, MD; PhD
Organizational Affiliation
University Hospital in Angers (France)
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital
City
Angers
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
23312939
Citation
Abraham P, Mateus V, Bieuzen F, Ouedraogo N, Cisse F, Leftheriotis G. Calf muscle stimulation with the Veinoplus device results in a significant increase in lower limb inflow without generating limb ischemia or pain in patients with peripheral artery disease. J Vasc Surg. 2013 Mar;57(3):714-9. doi: 10.1016/j.jvs.2012.08.117. Epub 2013 Jan 9.
Results Reference
derived
Learn more about this trial
Arterial Inflow and Muscle Ischemia During Calf Stimulation With the Veinoplus Device
We'll reach out to this number within 24 hrs